SCHEDULE 13D

Company

Theriva Biologics, Inc.

Filed

March 26, 1999

Accession Number

0000950136-99-000378

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →